On Friday, the same day Johnson & Johnson committed to spend $55 billion domestically over the next four years, company officials were in Eastern North Carolina to mark the first major investment ...

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

Grifols, S.A. stock has a Value Grade of B. Vanda Pharmaceuticals Inc. stock has a Value Grade of B. Answer a few questions and we'll show you five of the highest-graded stocks that align with your ...

Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors ...

Oxford Medical Products has announced positive three-month clinical trial results for Sirona, a weight-loss treatment aimed at overweight individuals and those transitioning off GLP-1 medications. The ...

1 Radboud University Medical Center, Radboud Institute for Health Sciences (RIHS), Nijmegen, The Netherlands Design We show how the prediction interval can help understand the uncertainty about ...

Hamilton was declared a paid-plasma-free zone in June, but Canadian Blood Services and Spanish health-care company Grifols are going ahead anyway with the centre in a lower-income area at 2255 ...

The net impact on the market is typically positive. Take Gotham City Research LLC’s dramatic assault on Grifols SA in January last year. The US hedge fund’s diatribe against the Spanish ...

It's time for an update on the Medical company Grifols, S.A. (NASDAQ:GRFS). It's been about 4 months since I last updated on the business, with that update being specific to an event where ...